Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome [2] (multiple letters)

New England Journal of Medicine

Volumn 340, Issue 17, 1999, Pages 1368-1369

  Sarkodee Adoo, C ^a   Gojo, I ^a   Heyman, M R ^a   Warwicker, P ^a   Goodship, J A ^a   Goodship, T H J ^a   Furlan, M ^a   Lammle, B ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC APPROACH ROUTE; DISEASE CLASSIFICATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; LETTER; PATIENT COUNSELING; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; METABOLISM; NOTE; BLOOD; IMMUNOLOGY;

ADAM PROTEIN; ADAMTS13 PROTEIN, HUMAN; METALLOPROTEINASE; VON WILLEBRAND FACTOR; AUTOANTIBODY; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H, HUMAN;

ADAM PROTEINS; DIAGNOSIS, DIFFERENTIAL; HEMOLYTIC-UREMIC SYNDROME; HUMANS; METALLOENDOPEPTIDASES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; VON WILLEBRAND FACTOR; AUTOANTIBODIES; COMPLEMENT FACTOR H;

EID: 0033614324     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904293401714     Document Type: Letter

References (0)